nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.044	0.0688	CbGbCtD
Eszopiclone—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.044	0.0688	CbGbCtD
Eszopiclone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0361	0.0564	CbGbCtD
Eszopiclone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.034	0.053	CbGbCtD
Eszopiclone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.034	0.053	CbGbCtD
Eszopiclone—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0334	0.0521	CbGbCtD
Eszopiclone—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0334	0.0521	CbGbCtD
Eszopiclone—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.032	0.05	CbGbCtD
Eszopiclone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0307	0.048	CbGbCtD
Eszopiclone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0307	0.048	CbGbCtD
Eszopiclone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0265	0.0414	CbGbCtD
Eszopiclone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0257	0.0402	CbGbCtD
Eszopiclone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0233	0.0364	CbGbCtD
Eszopiclone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0233	0.0364	CbGbCtD
Eszopiclone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0223	0.0349	CbGbCtD
Eszopiclone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.021	0.0328	CbGbCtD
Eszopiclone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0197	0.0308	CbGbCtD
Eszopiclone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0197	0.0308	CbGbCtD
Eszopiclone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0179	0.0279	CbGbCtD
Eszopiclone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0179	0.0279	CbGbCtD
Eszopiclone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0241	CbGbCtD
Eszopiclone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.015	0.0234	CbGbCtD
Eszopiclone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0135	0.0211	CbGbCtD
Eszopiclone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0135	0.0211	CbGbCtD
Eszopiclone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.013	0.0203	CbGbCtD
Eszopiclone—TSPO—blood plasma—acquired immunodeficiency syndrome	0.00209	0.0433	CbGeAlD
Eszopiclone—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0297	CbGeAlD
Eszopiclone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00131	0.0271	CbGeAlD
Eszopiclone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00127	0.0264	CbGeAlD
Eszopiclone—GABRG3—nervous system—acquired immunodeficiency syndrome	0.00126	0.0261	CbGeAlD
Eszopiclone—GABRG3—central nervous system—acquired immunodeficiency syndrome	0.00121	0.0251	CbGeAlD
Eszopiclone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00116	0.0241	CbGeAlD
Eszopiclone—TSPO—retina—acquired immunodeficiency syndrome	0.00114	0.0237	CbGeAlD
Eszopiclone—TSPO—skin of body—acquired immunodeficiency syndrome	0.001	0.0208	CbGeAlD
Eszopiclone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000972	0.0201	CbGeAlD
Eszopiclone—GABRA5—nervous system—acquired immunodeficiency syndrome	0.000968	0.02	CbGeAlD
Eszopiclone—GABRG3—brain—acquired immunodeficiency syndrome	0.000963	0.0199	CbGeAlD
Eszopiclone—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.000932	0.0193	CbGeAlD
Eszopiclone—GABRA3—nervous system—acquired immunodeficiency syndrome	0.000902	0.0187	CbGeAlD
Eszopiclone—GABRA4—nervous system—acquired immunodeficiency syndrome	0.000879	0.0182	CbGeAlD
Eszopiclone—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.000872	0.0181	CbGeAlD
Eszopiclone—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.000872	0.0181	CbGeAlD
Eszopiclone—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.000868	0.018	CbGeAlD
Eszopiclone—GABRA4—central nervous system—acquired immunodeficiency syndrome	0.000846	0.0175	CbGeAlD
Eszopiclone—TSPO—lymphoid tissue—acquired immunodeficiency syndrome	0.000814	0.0168	CbGeAlD
Eszopiclone—TSPO—digestive system—acquired immunodeficiency syndrome	0.000804	0.0166	CbGeAlD
Eszopiclone—GABRB2—lung—acquired immunodeficiency syndrome	0.000794	0.0164	CbGeAlD
Eszopiclone—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.00077	0.0159	CbGeAlD
Eszopiclone—GABRA2—vagina—acquired immunodeficiency syndrome	0.000767	0.0159	CbGeAlD
Eszopiclone—TSPO—blood—acquired immunodeficiency syndrome	0.000766	0.0159	CbGeAlD
Eszopiclone—TSPO—bone marrow—acquired immunodeficiency syndrome	0.000741	0.0153	CbGeAlD
Eszopiclone—GABRA5—brain—acquired immunodeficiency syndrome	0.00074	0.0153	CbGeAlD
Eszopiclone—TSPO—spinal cord—acquired immunodeficiency syndrome	0.000738	0.0153	CbGeAlD
Eszopiclone—GABRG2—nervous system—acquired immunodeficiency syndrome	0.000735	0.0152	CbGeAlD
Eszopiclone—GABRB2—nervous system—acquired immunodeficiency syndrome	0.000735	0.0152	CbGeAlD
Eszopiclone—TSPO—vagina—acquired immunodeficiency syndrome	0.00071	0.0147	CbGeAlD
Eszopiclone—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.000708	0.0146	CbGeAlD
Eszopiclone—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.000708	0.0146	CbGeAlD
Eszopiclone—GABRA3—brain—acquired immunodeficiency syndrome	0.000689	0.0143	CbGeAlD
Eszopiclone—GABRA4—brain—acquired immunodeficiency syndrome	0.000672	0.0139	CbGeAlD
Eszopiclone—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000671	0.0139	CbGeAlD
Eszopiclone—TSPO—lung—acquired immunodeficiency syndrome	0.000671	0.0139	CbGeAlD
Eszopiclone—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000649	0.0134	CbGeAlD
Eszopiclone—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000646	0.0134	CbGeAlD
Eszopiclone—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000625	0.0129	CbGeAlD
Eszopiclone—TSPO—nervous system—acquired immunodeficiency syndrome	0.000622	0.0129	CbGeAlD
Eszopiclone—TSPO—central nervous system—acquired immunodeficiency syndrome	0.000598	0.0124	CbGeAlD
Eszopiclone—GABRB2—brain—acquired immunodeficiency syndrome	0.000562	0.0116	CbGeAlD
Eszopiclone—GABRG2—brain—acquired immunodeficiency syndrome	0.000562	0.0116	CbGeAlD
Eszopiclone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000559	0.0116	CbGeAlD
Eszopiclone—CYP2C8—blood—acquired immunodeficiency syndrome	0.000525	0.0109	CbGeAlD
Eszopiclone—GABRA2—brain—acquired immunodeficiency syndrome	0.000513	0.0106	CbGeAlD
Eszopiclone—GABRA1—brain—acquired immunodeficiency syndrome	0.000496	0.0103	CbGeAlD
Eszopiclone—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000496	0.0103	CbGeAlD
Eszopiclone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00049	0.0101	CbGeAlD
Eszopiclone—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000487	0.0101	CbGeAlD
Eszopiclone—TSPO—brain—acquired immunodeficiency syndrome	0.000475	0.00984	CbGeAlD
Eszopiclone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000467	0.00966	CbGeAlD
Eszopiclone—TSPO—lymph node—acquired immunodeficiency syndrome	0.000459	0.0095	CbGeAlD
Eszopiclone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000447	0.00926	CbGeAlD
Eszopiclone—PTGS1—blood—acquired immunodeficiency syndrome	0.000426	0.00882	CbGeAlD
Eszopiclone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000411	0.0085	CbGeAlD
Eszopiclone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000395	0.00818	CbGeAlD
Eszopiclone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000374	0.00773	CbGeAlD
Eszopiclone—PTGS1—lung—acquired immunodeficiency syndrome	0.000374	0.00773	CbGeAlD
Eszopiclone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000356	0.00737	CbGeAlD
Eszopiclone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000346	0.00716	CbGeAlD
Eszopiclone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000333	0.00689	CbGeAlD
Eszopiclone—CYP2C8—brain—acquired immunodeficiency syndrome	0.000326	0.00675	CbGeAlD
Eszopiclone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000289	0.00598	CbGeAlD
Eszopiclone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000278	0.00576	CbGeAlD
Eszopiclone—PTGS1—brain—acquired immunodeficiency syndrome	0.000264	0.00547	CbGeAlD
Eszopiclone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000255	0.00529	CbGeAlD
Eszopiclone—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000454	CcSEcCtD
Eszopiclone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000454	CcSEcCtD
Eszopiclone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000141	0.000454	CcSEcCtD
Eszopiclone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000141	0.000453	CcSEcCtD
Eszopiclone—Headache—Didanosine—acquired immunodeficiency syndrome	0.000141	0.000451	CcSEcCtD
Eszopiclone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00014	0.00045	CcSEcCtD
Eszopiclone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.00045	CcSEcCtD
Eszopiclone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000449	CcSEcCtD
Eszopiclone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000449	CcSEcCtD
Eszopiclone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00014	0.000448	CcSEcCtD
Eszopiclone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000448	CcSEcCtD
Eszopiclone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000448	CcSEcCtD
Eszopiclone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000447	CcSEcCtD
Eszopiclone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000447	CcSEcCtD
Eszopiclone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000446	CcSEcCtD
Eszopiclone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000445	CcSEcCtD
Eszopiclone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000445	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000444	CcSEcCtD
Eszopiclone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000443	CcSEcCtD
Eszopiclone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000138	0.000443	CcSEcCtD
Eszopiclone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000442	CcSEcCtD
Eszopiclone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000138	0.000442	CcSEcCtD
Eszopiclone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000441	CcSEcCtD
Eszopiclone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000441	CcSEcCtD
Eszopiclone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000441	CcSEcCtD
Eszopiclone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000441	CcSEcCtD
Eszopiclone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000137	0.000439	CcSEcCtD
Eszopiclone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000439	CcSEcCtD
Eszopiclone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000439	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000436	CcSEcCtD
Eszopiclone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000436	CcSEcCtD
Eszopiclone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000436	CcSEcCtD
Eszopiclone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000435	CcSEcCtD
Eszopiclone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000435	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000435	CcSEcCtD
Eszopiclone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000434	CcSEcCtD
Eszopiclone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000432	CcSEcCtD
Eszopiclone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000432	CcSEcCtD
Eszopiclone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000432	CcSEcCtD
Eszopiclone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000431	CcSEcCtD
Eszopiclone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000431	CcSEcCtD
Eszopiclone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000431	CcSEcCtD
Eszopiclone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.00043	CcSEcCtD
Eszopiclone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000429	CcSEcCtD
Eszopiclone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000429	CcSEcCtD
Eszopiclone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.000429	CcSEcCtD
Eszopiclone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000429	CcSEcCtD
Eszopiclone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000428	CcSEcCtD
Eszopiclone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000428	CcSEcCtD
Eszopiclone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000133	0.000428	CcSEcCtD
Eszopiclone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000427	CcSEcCtD
Eszopiclone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000426	CcSEcCtD
Eszopiclone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000425	CcSEcCtD
Eszopiclone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000424	CcSEcCtD
Eszopiclone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000424	CcSEcCtD
Eszopiclone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000424	CcSEcCtD
Eszopiclone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000423	CcSEcCtD
Eszopiclone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000421	CcSEcCtD
Eszopiclone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.00042	CcSEcCtD
Eszopiclone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000419	CcSEcCtD
Eszopiclone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000416	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000416	CcSEcCtD
Eszopiclone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000415	CcSEcCtD
Eszopiclone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000415	CcSEcCtD
Eszopiclone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000415	CcSEcCtD
Eszopiclone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000129	0.000413	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000413	CcSEcCtD
Eszopiclone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000413	CcSEcCtD
Eszopiclone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000412	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000412	CcSEcCtD
Eszopiclone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000412	CcSEcCtD
Eszopiclone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000128	0.000412	CcSEcCtD
Eszopiclone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000411	CcSEcCtD
Eszopiclone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.00041	CcSEcCtD
Eszopiclone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00041	CcSEcCtD
Eszopiclone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000408	CcSEcCtD
Eszopiclone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000408	CcSEcCtD
Eszopiclone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000408	CcSEcCtD
Eszopiclone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.000408	CcSEcCtD
Eszopiclone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.000408	CcSEcCtD
Eszopiclone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000407	CcSEcCtD
Eszopiclone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000127	0.000407	CcSEcCtD
Eszopiclone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000406	CcSEcCtD
Eszopiclone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.000405	CcSEcCtD
Eszopiclone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000404	CcSEcCtD
Eszopiclone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000404	CcSEcCtD
Eszopiclone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000404	CcSEcCtD
Eszopiclone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000403	CcSEcCtD
Eszopiclone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000403	CcSEcCtD
Eszopiclone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000402	CcSEcCtD
Eszopiclone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000401	CcSEcCtD
Eszopiclone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.0004	CcSEcCtD
Eszopiclone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000399	CcSEcCtD
Eszopiclone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000399	CcSEcCtD
Eszopiclone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000124	0.000399	CcSEcCtD
Eszopiclone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000124	0.000397	CcSEcCtD
Eszopiclone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000124	0.000397	CcSEcCtD
Eszopiclone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000396	CcSEcCtD
Eszopiclone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000395	CcSEcCtD
Eszopiclone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000395	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000394	CcSEcCtD
Eszopiclone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000123	0.000394	CcSEcCtD
Eszopiclone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000394	CcSEcCtD
Eszopiclone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000123	0.000394	CcSEcCtD
Eszopiclone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000393	CcSEcCtD
Eszopiclone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000393	CcSEcCtD
Eszopiclone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.000393	CcSEcCtD
Eszopiclone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000391	CcSEcCtD
Eszopiclone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000122	0.000391	CcSEcCtD
Eszopiclone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000391	CcSEcCtD
Eszopiclone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00039	CcSEcCtD
Eszopiclone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.00039	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.00039	CcSEcCtD
Eszopiclone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.00039	CcSEcCtD
Eszopiclone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000388	CcSEcCtD
Eszopiclone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000388	CcSEcCtD
Eszopiclone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000388	CcSEcCtD
Eszopiclone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000387	CcSEcCtD
Eszopiclone—Headache—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000386	CcSEcCtD
Eszopiclone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000385	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000385	CcSEcCtD
Eszopiclone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00012	0.000384	CcSEcCtD
Eszopiclone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000384	CcSEcCtD
Eszopiclone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000382	CcSEcCtD
Eszopiclone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000379	CcSEcCtD
Eszopiclone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000379	CcSEcCtD
Eszopiclone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000377	CcSEcCtD
Eszopiclone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000377	CcSEcCtD
Eszopiclone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000376	CcSEcCtD
Eszopiclone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000376	CcSEcCtD
Eszopiclone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000375	CcSEcCtD
Eszopiclone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000375	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000373	CcSEcCtD
Eszopiclone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.000372	CcSEcCtD
Eszopiclone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000372	CcSEcCtD
Eszopiclone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000372	CcSEcCtD
Eszopiclone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000372	CcSEcCtD
Eszopiclone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000371	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00037	CcSEcCtD
Eszopiclone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00037	CcSEcCtD
Eszopiclone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000368	CcSEcCtD
Eszopiclone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000367	CcSEcCtD
Eszopiclone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000366	CcSEcCtD
Eszopiclone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000365	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000365	CcSEcCtD
Eszopiclone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000364	CcSEcCtD
Eszopiclone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000363	CcSEcCtD
Eszopiclone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000362	CcSEcCtD
Eszopiclone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000362	CcSEcCtD
Eszopiclone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000361	CcSEcCtD
Eszopiclone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000361	CcSEcCtD
Eszopiclone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000361	CcSEcCtD
Eszopiclone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000361	CcSEcCtD
Eszopiclone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000361	CcSEcCtD
Eszopiclone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000112	0.000359	CcSEcCtD
Eszopiclone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000358	CcSEcCtD
Eszopiclone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000357	CcSEcCtD
Eszopiclone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000353	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000353	CcSEcCtD
Eszopiclone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000352	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000351	CcSEcCtD
Eszopiclone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000351	CcSEcCtD
Eszopiclone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.00035	CcSEcCtD
Eszopiclone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000348	CcSEcCtD
Eszopiclone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000348	CcSEcCtD
Eszopiclone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000348	CcSEcCtD
Eszopiclone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000348	CcSEcCtD
Eszopiclone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000346	CcSEcCtD
Eszopiclone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000346	CcSEcCtD
Eszopiclone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000108	0.000345	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000345	CcSEcCtD
Eszopiclone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000345	CcSEcCtD
Eszopiclone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000342	CcSEcCtD
Eszopiclone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000342	CcSEcCtD
Eszopiclone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000342	CcSEcCtD
Eszopiclone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000341	CcSEcCtD
Eszopiclone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.00034	CcSEcCtD
Eszopiclone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000338	CcSEcCtD
Eszopiclone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000337	CcSEcCtD
Eszopiclone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000336	CcSEcCtD
Eszopiclone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000335	CcSEcCtD
Eszopiclone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000335	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000335	CcSEcCtD
Eszopiclone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000334	CcSEcCtD
Eszopiclone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000334	CcSEcCtD
Eszopiclone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000334	CcSEcCtD
Eszopiclone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000334	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000332	CcSEcCtD
Eszopiclone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000332	CcSEcCtD
Eszopiclone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000332	CcSEcCtD
Eszopiclone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000328	CcSEcCtD
Eszopiclone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000327	CcSEcCtD
Eszopiclone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000323	CcSEcCtD
Eszopiclone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000323	CcSEcCtD
Eszopiclone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000323	CcSEcCtD
Eszopiclone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000321	CcSEcCtD
Eszopiclone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000321	CcSEcCtD
Eszopiclone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.0001	0.000321	CcSEcCtD
Eszopiclone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.96e-05	0.00032	CcSEcCtD
Eszopiclone—Rash—Indinavir—acquired immunodeficiency syndrome	9.93e-05	0.000318	CcSEcCtD
Eszopiclone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.92e-05	0.000318	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.88e-05	0.000317	CcSEcCtD
Eszopiclone—Headache—Indinavir—acquired immunodeficiency syndrome	9.86e-05	0.000316	CcSEcCtD
Eszopiclone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.84e-05	0.000316	CcSEcCtD
Eszopiclone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.74e-05	0.000312	CcSEcCtD
Eszopiclone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.7e-05	0.000311	CcSEcCtD
Eszopiclone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.6e-05	0.000308	CcSEcCtD
Eszopiclone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.55e-05	0.000307	CcSEcCtD
Eszopiclone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.55e-05	0.000307	CcSEcCtD
Eszopiclone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.46e-05	0.000303	CcSEcCtD
Eszopiclone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.44e-05	0.000303	CcSEcCtD
Eszopiclone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.41e-05	0.000302	CcSEcCtD
Eszopiclone—Rash—Efavirenz—acquired immunodeficiency syndrome	9.38e-05	0.000301	CcSEcCtD
Eszopiclone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.37e-05	0.000301	CcSEcCtD
Eszopiclone—Nausea—Indinavir—acquired immunodeficiency syndrome	9.35e-05	0.0003	CcSEcCtD
Eszopiclone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.33e-05	0.000299	CcSEcCtD
Eszopiclone—Headache—Efavirenz—acquired immunodeficiency syndrome	9.32e-05	0.000299	CcSEcCtD
Eszopiclone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.31e-05	0.000299	CcSEcCtD
Eszopiclone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.09e-05	0.000292	CcSEcCtD
Eszopiclone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.05e-05	0.00029	CcSEcCtD
Eszopiclone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9e-05	0.000289	CcSEcCtD
Eszopiclone—Rash—Delavirdine—acquired immunodeficiency syndrome	8.97e-05	0.000288	CcSEcCtD
Eszopiclone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.96e-05	0.000288	CcSEcCtD
Eszopiclone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.96e-05	0.000288	CcSEcCtD
Eszopiclone—Headache—Delavirdine—acquired immunodeficiency syndrome	8.91e-05	0.000286	CcSEcCtD
Eszopiclone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.000286	CcSEcCtD
Eszopiclone—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.83e-05	0.000283	CcSEcCtD
Eszopiclone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.7e-05	0.000279	CcSEcCtD
Eszopiclone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.67e-05	0.000278	CcSEcCtD
Eszopiclone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000278	CcSEcCtD
Eszopiclone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000274	CcSEcCtD
Eszopiclone—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.45e-05	0.000271	CcSEcCtD
Eszopiclone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.38e-05	0.000269	CcSEcCtD
Eszopiclone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.37e-05	0.000268	CcSEcCtD
Eszopiclone—Rash—Ritonavir—acquired immunodeficiency syndrome	8.3e-05	0.000266	CcSEcCtD
Eszopiclone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.29e-05	0.000266	CcSEcCtD
Eszopiclone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.000265	CcSEcCtD
Eszopiclone—Headache—Ritonavir—acquired immunodeficiency syndrome	8.24e-05	0.000265	CcSEcCtD
Eszopiclone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.05e-05	0.000258	CcSEcCtD
Eszopiclone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.99e-05	0.000256	CcSEcCtD
Eszopiclone—Rash—Saquinavir—acquired immunodeficiency syndrome	7.99e-05	0.000256	CcSEcCtD
Eszopiclone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.98e-05	0.000256	CcSEcCtD
Eszopiclone—Headache—Saquinavir—acquired immunodeficiency syndrome	7.93e-05	0.000255	CcSEcCtD
Eszopiclone—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.000251	CcSEcCtD
Eszopiclone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.68e-05	0.000247	CcSEcCtD
Eszopiclone—Rash—Lamivudine—acquired immunodeficiency syndrome	7.62e-05	0.000244	CcSEcCtD
Eszopiclone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.61e-05	0.000244	CcSEcCtD
Eszopiclone—Headache—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000243	CcSEcCtD
Eszopiclone—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.52e-05	0.000241	CcSEcCtD
Eszopiclone—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.00023	CcSEcCtD
